NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | XF417D3PSL |
| Ibuprofen | IBUPROFEN | NuCare Pharmaceuticals, Inc. | 23fb1113-9f1c-88e0-e063-6394a90a4450 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | P & L Development, LLC | 1f9c94a6-938a-420f-b90c-36b3791e97ad | 2024-10-07 | Warnings | WK2XYI10QM |
| Bio Co-Enzyme Phase | CARDUUS MARIANUS, ASCORBICUM ACIDUM, CYSTEINUM, NATRUM OXALACETICUM, NICOTINAMIDUM, PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CERIUM OXALICUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, NADIDUM, NATRUM PYRUVICUM, PANTOTHENIC ACID, SUCCINICUM ACIDUM, ADRENALINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, HEPAR SULPHURIS CALCAREUM, SULPHUR, ACONITICUM ACIDUM, CIS-, | Deseret Biologicals, Inc. | afad858e-064f-454d-be78-da1501ffe853 | 2024-10-04 | Warnings | XF417D3PSL |
| dual action pain reliever | ACETAMINOPHEN AND IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 2397603c-8d87-2e65-e063-6394a90ab73e | 2024-10-03 | Warnings | WK2XYI10QM |
| dual action pain reliever | ACETAMINOPHEN AND IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 23994b21-cbc2-5a34-e063-6394a90acfdf | 2024-10-03 | Warnings | WK2XYI10QM |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | XF417D3PSL |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 43ac478c-43db-4136-8fee-4a43b09681e5 | 2024-10-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | H E B | 2f193146-74b2-4941-893d-3d2f5c8ee659 | 2024-10-01 | Warnings | WK2XYI10QM |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 204e84a7-5440-4537-9e40-06eb56c415e9 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Sodium Phenylacetate and sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | fbc7bfe3-6faa-45a3-befb-9ad7963c0571 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Ibuprofen 200mg | IBUPROFEN 200MG | Allegiant Health | 265e2b47-d14a-45a8-adc0-7214e2057103 | 2024-09-30 | Warnings | WK2XYI10QM |
| hemorrhoidal maximum strength pain relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Kroger Company | 3c8f90e2-fecf-4439-9faa-81a32ffe4753 | 2024-09-26 | Warnings | PDC6A3C0OX |
| equate hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Wal-Mart Stores Inc | 5ccefdbd-bbbe-4cbf-9fdb-3c568643e14d | 2024-09-26 | Warnings | PDC6A3C0OX |
| Dual Action Pain Relief | ACETAMINOPHEN, IBUPROFEN | TARGET CORPORATION | e680652b-30d8-6009-e053-2995a90abe29 | 2024-09-25 | Warnings | WK2XYI10QM |
| Advanced Eye Relief/ Redness Maximum Relief | NAPHAZOLINE HYDROCHLORIDE AND HYPROMELLOSE | Bausch & Lomb Incorporated | 3c11285a-7e86-4b47-b1ee-e7d59858087d | 2024-09-25 | Warnings | 3NXW29V3WO |
| Walgreens Hemorrhoidal Pain Relief | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Walgreens | e79ed7ae-0d06-2f88-e053-2995a90a1e35 | 2024-09-20 | Warnings | PDC6A3C0OX |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | PDC6A3C0OX |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | XF417D3PSL |
| basic care ibuprofen pm | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Amazon.com Services LLC | 6bd8bad2-4370-4450-822a-9ef50949a8fc | 2024-09-09 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.